Beyond Air, Inc. Increase (Decrease) in Accrued Liabilities
Beyond Air, Inc. (XAIR) reported Increase (Decrease) in Accrued Liabilities of -$2.26 million for the 9-month period ending 2022-12-31, per its 10-Q filed 2023-02-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2023-02-10
- Beyond Air, Inc. increase (decrease) in accrued liabilities for the quarter ending 2022-12-31 was $852.00K.
- Beyond Air, Inc. increase (decrease) in accrued liabilities for the quarter ending 2021-12-31 was -$50.00K, a 157.47% decline year-over-year.
- Beyond Air, Inc. increase (decrease) in accrued liabilities for the quarter ending 2021-09-30 was $2.66M, a 912.33% increase year-over-year.
- Beyond Air, Inc. increase (decrease) in accrued liabilities for the quarter ending 2021-06-30 was -$109.70K.
- Beyond Air, Inc. increase (decrease) in accrued liabilities for fiscal 2021 was -$447.40K.
- Beyond Air, Inc. increase (decrease) in accrued liabilities for fiscal 2020 was -$470.11K, a 269.86% decline from fiscal 2019.
- Beyond Air, Inc. increase (decrease) in accrued liabilities for fiscal 2019 was $276.76K, a 40.59% increase from fiscal 2018.
- Beyond Air, Inc. increase (decrease) in accrued liabilities for fiscal 2018 was $196.85K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | $852.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-10 | -$2.26M 10-Q · filed 2023-02-10 | ||||
| 2022-09-30 | -$3.11M 10-Q · filed 2022-11-08 | |||||
| 2021-12-31 | -$50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-10 | $2.61M derived: sum of 2 quarters · filed 2023-02-10 | $2.50M 10-Q · filed 2023-02-10 | $1.72M derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-09-30 | $2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-08 | $2.55M 10-Q · filed 2022-11-08 | $1.77M derived: sum of 3 quarters · filed 2022-11-08 | $1.85M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | -$109.70K 10-Q · filed 2021-08-10 | -$894.10K derived: sum of 2 quarters · filed 2021-08-10 | -$807.10K derived: sum of 3 quarters · filed 2022-02-10 | -$544.27K derived: sum of 4 quarters · filed 2022-02-10 | ||
| 2021-03-31 | -$784.40K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-10 | -$697.40K derived: sum of 2 quarters · filed 2022-02-10 | -$434.57K derived: sum of 3 quarters · filed 2022-02-10 | -$447.40K 10-K · filed 2021-06-10 | ||
| 2020-12-31 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-10 | $349.83K derived: sum of 2 quarters · filed 2022-02-10 | $337.00K 10-Q · filed 2022-02-10 | $336.55K 10-Q · filed 2021-02-09 | -$240.54K derived: sum of 4 quarters · filed 2022-02-10 | |
| 2020-09-30 | $262.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-12 | $250.00K 10-Q · filed 2021-11-12 | $249.97K 10-Q · filed 2020-11-12 | -$327.54K derived: sum of 3 quarters · filed 2021-11-12 | -$720.72K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | -$12.83K 10-Q · filed 2021-08-10 | -$590.37K derived: sum of 2 quarters · filed 2021-08-10 | -$983.54K derived: sum of 3 quarters · filed 2021-08-10 | -$429.85K derived: sum of 4 quarters · filed 2021-08-10 | ||
| 2020-03-31 | -$577.54K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-10 | -$970.72K derived: sum of 2 quarters · filed 2021-06-10 | -$417.02K derived: sum of 3 quarters · filed 2021-06-10 | -$470.11K 10-K · filed 2021-06-10 | ||
| 2019-12-31 | -$393.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09 | $160.52K derived: sum of 2 quarters · filed 2021-02-09 | $107.43K 10-Q · filed 2021-02-09 | $1.35M derived: sum of 4 quarters · filed 2021-02-09 | ||
| 2019-09-30 | $553.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-12 | $500.61K 10-Q · filed 2020-11-12 | $1.74M derived: sum of 3 quarters · filed 2020-11-12 | $1.67M derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | -$53.09K 10-Q · filed 2020-08-06 | $1.19M derived: sum of 2 quarters · filed 2020-08-06 | $1.12M derived: sum of 3 quarters · filed 2020-08-06 | $754.70K derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-23 | $1.17M derived: sum of 2 quarters · filed 2020-06-23 | $807.79K derived: sum of 3 quarters · filed 2020-06-23 | $276.76K 10-K · filed 2020-06-23 | ||
| 2018-12-31 | -$71.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-07 | -$435.78K derived: sum of 2 quarters · filed 2020-02-07 | -$966.82K 10-Q · filed 2020-02-07 | -$968.29K 10-Q · filed 2019-02-14 | -$654.33K derived: sum of 4 quarters · filed 2020-02-07 | |
| 2018-09-30 | -$364.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-06 | -$895.25K 10-Q · filed 2019-11-06 | -$909.00K 10-Q · filed 2018-11-14 | -$582.76K derived: sum of 3 quarters · filed 2019-11-06 | -$523.61K derived: sum of 4 quarters · filed 2019-11-06 | |
| 2018-06-30 | -$531.04K 10-Q · filed 2019-08-14 | -$218.54K derived: sum of 2 quarters · filed 2019-08-14 | -$159.40K derived: sum of 3 quarters · filed 2019-08-14 | |||
| 2018-03-31 | $312.50K 10-K · filed 2019-06-28 | $371.64K derived: sum of 2 quarters · filed 2019-06-28 | $196.85K 10-K · filed 2019-06-28 | |||
| 2017-12-31 | $59.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | -$163.86K 10-Q · filed 2019-02-14 | -$573.62K 10-K · filed 2019-06-28 | |||
| 2017-09-30 | -$223.00K 10-Q · filed 2018-11-14 | |||||
| 2017-03-31 | -$409.73K 10-K · filed 2019-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |